Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  • Attrezzature

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  • Attrezzature
  1. Pubblicazioni

Major salivary gland carcinomas: A 21-center cohort study of 892 patients with external validation of the UICC 9th edition n-classification

Articolo
Data di Pubblicazione:
2026
Citazione:
Major salivary gland carcinomas: A 21-center cohort study of 892 patients with external validation of the UICC 9th edition n-classification / De Luca, P., Salzano, G., Simone, M., Petruzzi, G., Marchi, F., Filauro, M., Elisa, B., Fermi, M., Amato, N., Sacchetto, A., Mercuri, E., Fior, M., Scocca, V., Alberti, C., Guarino, P., Chiari, F., Ruaro, A., Negrisolo, M., Gazzini, L., Thaler, M., et al.. - In: ORAL ONCOLOGY. - ISSN 1368-8375. - 182:(2026). [10.1016/j.oraloncology.2026.108136]
Abstract:
Objectives: Major salivary gland carcinomas are rare malignancies with limited prognostic evidence. This study assessed survival outcomes, independent prognostic factors, intraparotid lymph node involvement, and stromal tumor-infiltrating lymphocyte (sTIL) density. Materials and Methods: Multicenter retrospective cohort study of 892 patients, classified per the 2022 WHO Classification, treated surgically at 21 Italian referral centers (2010–2023). Results: Median follow-up 61.4 months. The cohort included 61.1% males, median age 59.0 years; parotid gland was the primary site in 90.4%. AdCC (28.4%) and MEC (27.2%) were most frequent; 63.8% at Stage I–II. Five-year OS, DSS, and RFS were 87.9% (95% CI 85.4–90.1%), 93.1% (91.0–94.8%), and 77.7% (74.6–80.4%). Histological facial nerve infiltration was the most robust independent prognostic factor across all endpoints (OS: HR 1.78, 95% CI 1.12–2.81; DSS: HR 2.49, 1.37–4.50; RFS: HR 2.22, 1.54–3.21). Age, lymphovascular invasion, and atypical mitoses were additional independent predictors. Among 688 parotid patients with intraparotid nodal data available, 29.2% had intraparotid metastasis; 60.7% lacked cervical involvement, with LN+/pN0 patients showing worse RFS than LN-negative patients (71.2% vs 85.3%; p = 0.002). In 285 patients with available sTIL assessment (32.0%), higher sTIL density predicted improved RFS (HR 0.51 per 10% increment, 95% CI 0.35–0.73; p < 0.001). UICC 9th edition restaging reclassified 27.3% of pN0 patients as node-positive, with significant survival stratification (p < 0.001). Conclusions: Histological facial nerve infiltration was the most consistently independent prognostic factor, supporting systematic pathological reporting. Current TNM N-staging may inadequately capture intraparotid lymph node involvement, and sTILs showed a continuous prognostic effect on RFS, supporting prospective biomarker validation.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Competing risk analysis; Disease-specific survival; Facial nerve infiltration; Intraparotid lymph node metastasis; Lymphovascular invasion; Multicentre cohort study; Prognostic factors; Salivary gland carcinoma; TNM staging; Tumor-infiltrating lymphocytes
Elenco autori:
De Luca, Pietro; Salzano, Giovanni; Simone, Matteo; Petruzzi, Gerardo; Marchi, Filippo; Filauro, Marta; Elisa, Bellini; Fermi, Matteo; Amato, Nicola; Sacchetto, Andrea; Mercuri, Elena; Fior, Milena; Scocca, Veronica; Alberti, Chiara; Guarino, Pierre; Chiari, Francesco; Ruaro, Alessandra; Negrisolo, Michael; Gazzini, Luca; Thaler, Markus; Gardenal, Nicoletta; Marcuzzo, Alberto Vito; Aragona, Teodoro; Ruzza, Annamaria; Falchetta, Luigi; Semeskandi, Alice Azizi; Pangallo, Sofia; Capuano, Francesco; De Campora, Luca; Mattioli, Francesco; Ferreli, Fabio; Crescio, Claudia; Rizzo, Davide; Scarpa, Alfonso; Lucante, Teresa; Crosetti, Erika; Peretti, Giorgio; Mercante, Giuseppe; Caporale, Claudio Donadio; Stadio, Arianna Di; D'Ecclesia, Aurelio; Marchioni, Daniele; Tirelli, Giancarlo; Cassano, Lazzaro; Orabona, Giovanni Dell'Aversana; Calabrese, Luca; Ferrari, Marco; Saetti, Roberto; Succo, Giovanni; Salzano, Francesco Antonio; Spriano, Giuseppe; Tortoriello, Giuseppe; Pellini, Raul; Bussu, Francesco; Viti, Claudio; Radici, Marco; Camaioni, Angelo
Autori di Ateneo:
BUSSU Francesco
RIZZO Davide
Link alla scheda completa:
https://iris.uniss.it/handle/11388/394209
Pubblicato in:
ORAL ONCOLOGY
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.11.1.0